Dianthus Therapeutics Inc banner

Wall St Price Targets

DNTH Price Forecast
Based on 17 analysts

+52% Upside
from $89.3 today

Dianthus Therapeutics Inc (DNTH)’s 12-month stock price forecast through November 2027 has a consensus target of $135.66, implying 52% upside. The forecast is based on price targets from 17 Wall Street analysts.

DNTH Analyst Rating
Based on 18 analysts

avg. 4.94 of 5
Strong buy
17 94%
Buy
1 6%
Hold
0 0%
Sell
0 0%
Strong sell
0 0%

Analysts rate DNTH Strong buy, with 18 of 18 recommending Buy or Strong buy.

Dianthus Therapeutics Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is DNTH's stock price target?
Price Target
135.66 USD

According to Wall Street analysts, the average 1-year price target for DNTH is 135.66 USD with a low forecast of 114.13 USD and a high forecast of 210 USD.

What is the Revenue forecast for Dianthus Therapeutics Inc?
Projected CAGR
143%

The compound annual growth rate for Revenue over the next 8 years is 143%.

Back to Top